Categories: All postsAnalysts

Paradigm lowers price target on AcuityAds, maintains buy rating

He still thinks AcuityAds (AcuityAds Stock Quote, Chart, News: TSXV:AT) is a great way for investors to play the adtech space, but in light of recent guidance revisions Paradigm Capital analyst Kevin Krishnaratne thinks it will take the company longer to get to where it’s going.

On Monday, AcuityAds issued a press release in which it said that, owing to various factors, it would not meet its previous guidance.

“”We feel strongly that our actions this quarter demonstrate that management has taken a long-term view to creating and enhancing shareholder value,” said CEO Tal Hayek. “When we see any activity that does not meet our high standards, we move swiftly and without compromise. When we acquire, we are meticulously focused on deal structure to mitigate risk. Despite these adjustments to our revenue guidance, we remain more committed than ever to both our organic and non-organic growth strategy.”

Krishnaratne says this development kicks the can down the road a bit.

“Acuity provided revenue updates for H2/17 that were well below our estimates and the Street’s. Our 2017 forecast moves lower by -25% to ~$60M to match management’s expectations that now imply relatively flattish organic growth for the year (+50% as reported when including M&A). While we still remain of the view that Acuity is one of the best ways to play the AdTech space and see multiple opportunities for upside to our estimates on the back of cross-selling initiatives, M&A, and the ongoing transition of media spending toward programmatic, we have taken a more conservative valuation approach.”

In a research update to clients today, Krishnaratne maintained his “Buy” rating on AcuityAds, but lowered his one-year price target on the stock from $8.00 to $3.75, implying a return of 74 per cent at the time of publication.

Krishnaratne thinks AcuityAds will generate EBITDA of $1.1-million on revenue of $30.5-million in fiscal 2017. He expects those numbers will improve to EBITDA of $5.6-million on a topline of $39.3-million the following year.

We Hate Paywalls Too!

At Cantech Letter we prize independent journalism like you do. And we don't care for paywalls and popups and all that noise That's why we need your support. If you value getting your daily information from the experts, won't you help us? No donation is too small.

Make a one-time or recurring donation

Nick Waddell

Cantech Letter founder and editor Nick Waddell has lived in five Canadian provinces and is proud of his country's often overlooked contributions to the world of science and technology. Waddell takes a regular shift on the Canadian media circuit, making appearances on CTV, CBC and BNN, and contributing to publications such as Canadian Business and Business Insider.

Recent Posts

Is Peloton Stock a Buy? (May, 2024)

Following news of a restructuring, Roth MKM analyst George Kelly has chopped his price target on Peloton (Peloton Stock Quote,… [Read More]

2 days ago

Is Ascend Wellness stock a buy?

Ahead of the company's first quarter results, Beacon analyst Russell Stanley thinks Ascend Wellness (Ascend Wellness Stock Quote, Chart, News,… [Read More]

2 days ago

Paradigm chops price target on Snipp Interactive

Following the company's fourth quarter results, Paradigm Capital analyst Daniel Rosenberg has cut his price target on Snipp Interactive (Snipp… [Read More]

2 days ago

It’s time to buy cannabis stocks, this analyst says

A major development came down the pipe this week at the U.S. Drug Enforcement Agency has reportedly decided to reschedule… [Read More]

3 days ago

Is Generac stock a buy?

Following the company's first quarter results, Roth MKM analyst Chip Moore remains neutral on Generac Holdings (Generac Holdings Stock Quote,… [Read More]

3 days ago

Bombardier is a buy, Desjardins says (May, 2024)

The stock has climbed slowly but surely since last October. But is there still money to be made on Bombardier?… [Read More]

3 days ago